Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

A Study to Evaluate the Efficacy and Safety of Subcutaneous Tildrakizumab in Subjects With Moderate to Severe Genital Psoriasis.

ClinicalTrials.gov ID: NCT06611163

Public ClinicalTrials.gov record NCT06611163. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 4:46 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-blind, Placebo Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Subcutaneous Tildrakizumab in Subjects With Moderate to Severe Genital Psoriasis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Phase 3 study to evaluate the efficacy and safety of subcutaneous Tildrakizumab in subjects with moderate to severe genital psoriasis.

Study identification

NCT ID
NCT06611163
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Enrollment
206 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 20, 2025
Primary completion
Jan 20, 2026
Completion
Jan 31, 2027
Last update posted
Aug 31, 2026

2025 – 2027

United States locations

U.S. sites
36
U.S. states
14
U.S. cities
33
Facility City State ZIP Site status
Smary Cures Clinical Research Anaheim California 92806
California Dermatology & Clinical Research Institute Encinitas California 92024
T. Joseph Raoof MD, Inc./Encino Research Center Encino California 91436
Center for Dermatology Clinical Research, Inc Fremont California 94538
Dermatology Research Associates Los Angeles California 90045
LA Universal Research Center Inc, Suite 1 Los Angeles California 90057
Amicis Research Center Northridge California 91324
Therapeutics Clinical Research San Diego California 92123
Dermatology Institute and Skin Care Center, Inc. DBA Clinical Science Institute Santa Monica California 90404
Paradigm Clinical Research Wheat Ridge Colorado 80033
Coral Gables Dermatology & Aesthetics Coral Cables Florida 33134
Florida Academic Centers Research and Education, LLC Coral Gables Florida 33134
Homestead Associates in Research Inc Homestead Florida 33033
Genomics Medical Research Miami Florida 33157
Med-Care Research Miami Florida 33165
Dermatology Affiliates Research Institute, LLC Atlanta Georgia 30305
Mcintosh Clinic, PC Thomasville Georgia 31792
The Indiana Clinical Trials Center Plainfield Indiana 46168
Oakland Hills Dermatology PC Auburn Hills Michigan 48326
The Derm Institute of West Michigan Caledonia Michigan 49316
Skin Specialists, PC Omaha Nebraska 68144
Forest Hills Dermatology Kew Gardens New York 11415
Equity Medical New York New York 10023
The Moses H. Cone Memorial Hospital Operating Corporation Greensboro North Carolina 27401
Hickory Dermatology Research Center, LLC Hickory North Carolina 28602
Javara Inc/ Tryon Medical Partners, PLLC Matthews North Carolina 28105
The Indiana Clinical Trials Center Optima Research Boardman Boardman Ohio 44512
Oregon Medical Research Center Portland Oregon 97201
Goodlettsville Dermatology Research Goodlettsville Tennessee 37072
Advanced Research Experts Nashville Tennessee 37211
Arlington Research Center, inc. Arlington Texas 76011
Center for Clinical Studies, LTD. LLP Houston Texas 77004
Progressive Clinical Research San Antonio Texas 78213
Texas Dermatology and Laser Specialists San Antonio Texas 78218
Center for Clinical Studies, LTD. LLP Webster Texas 77598
James Song, MD (James Song) Bellevue Washington 98004

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 20 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06611163, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 31, 2026 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06611163 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →